pharma · Total Laryngectomy · Breast Cancer · ATOS
ATOSSA THERAPEUTICS
ATOSSA THERAPEUTICS, INC.
ATOSSA THERAPEUTICS clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Torrance, USA
- Founded
- 2019
- Employees
- 36
- Programs
- 10
- Drugs
- 5
- Patents
- 8
ATOSSA THERAPEUTICS projects
7 ClinicalTrials.gov programs sponsored by ATOSSA THERAPEUTICS.
ATOSSA THERAPEUTICS has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
(Z)-endoxifen
ATOSSA THERAPEUTICS, INC.
Breast Neoplasms
1 trial -
ASCAPE-based follow-up strategy
ATOSSA THERAPEUTICS, INC.
Breast Cancer
1 trial -
Fulvestrant
ATOSSA THERAPEUTICS, INC.
Female Breast Carcinoma
1 trial -
Provox Vega voice prosthesis 22.5 Fr
ATOSSA THERAPEUTICS, INC.
Total Laryngectomy
1 trial -
Provox voice prosthesis
ATOSSA THERAPEUTICS, INC.
Total Laryngectomy
1 trial -
Topical endoxifen
ATOSSA THERAPEUTICS, INC.
Mammographic Breast Density
1 trial -
Z-Endoxifen
ATOSSA THERAPEUTICS, INC.
Breast Density
1 trial
Frequently asked questions
How many clinical projects does ATOSSA THERAPEUTICS have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.